RxDoctor Payments Data

Anne Baranano, MD

Retina Specialist · Biloxi, MSNPI 1295937183

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations.

$1,434in general payments, 2019–2025

Across 32 payments — averaging $44.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Apellis Pharmaceuticals, Inc.$329
  • Genentech USA, Inc.$303
  • Regeneron Healthcare Solutions, Inc.$267
  • AbbVie$212
  • Novartis$126
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$100
  • plus $98 from 3 others

What the payments were for

  • Food & beverage$1,41599%
  • Gifts$191%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few retina specialist providers in Mississippito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,988,654
Medicare patients
653
Services billed
19,993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate192$7,273
Brimonidine Tartrate54$6,398
Ketorolac Tromethamine87$2,914
Travoprost13$2,498
ValacyclovirValacyclovir Hcl19$1,538
Latanoprost91$858
Atropine Sulfate22$827
Fluorometholone15$798
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat40$589
Timolol Maleate50$397
Ofloxacin28$347
Dorzolamide Hcl13$248
ErythromycinErythromycin Base12$133
Acyclovir12$106

Paid to pharmacies, not to this prescriber.

Other retina specialist in Biloxi

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →